Clinical Trials
5
Active:4
Completed:1
Trial Phases
2 Phases
Phase 1:3
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (75.0%)Phase 3
1 (25.0%)Observational Study to Investigate the Effects of Training on the Administration of Cardioplexol™
Phase 3
Completed
- Conditions
- Coronary Artery Bypass SurgeryValve Surgery
- Interventions
- Drug: Cardioplegia Solution
- First Posted Date
- 2019-01-30
- Last Posted Date
- 2021-10-21
- Lead Sponsor
- Swiss Cardio Technologies AG
- Target Recruit Count
- 171
- Registration Number
- NCT03823521
- Locations
- 🇦🇹
Universitätsklinik Innsbruck, Innsbruck, Austria
🇦🇹Universitaetsklinikum Salzburg, Salzburg, Austria
🇦🇹Universitaetsklnikum St. Pölten, St. Pölten, Austria
News
Cardioplexol™ Demonstrates Safety and Efficacy in Phase 3 Trial for Cardiac Surgery
A pivotal phase 3 non-inferiority trial has confirmed the safety and efficacy of Cardioplexol™, a new low-volume cardioplegic solution, compared to standard Buckberg blood cardioplegia in cardiac surgeries.